Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Anti-Proteases and Alpha-1 Antitrypsin Augmentation Therapy.

Strange C.

Respir Care. 2018 Jun;63(6):690-698. doi: 10.4187/respcare.05933.

PMID:
29794204
2.

Mortality in Asthma-Chronic Obstructive Pulmonary Disease Overlap in the United States.

Kumbhare S, Strange C.

South Med J. 2018 May;111(5):293-298. doi: 10.14423/SMJ.0000000000000807.

PMID:
29767222
3.

Increasing multimorbidity in an Australian street health service: A 10-year retrospective cohort study

Arnold-Reed D, Troeung L, Brett T, Chan She Ping-Delfos W, Strange C, Geelhoed E, Fisher C, Preen D.

Aust J Gen Pract. 2018 Apr;47(4):181-189.

4.

A general practice street health service

Strange C, Fisher C, Ping-Delfos WCS, Arnold-Reed D, Brett T.

Aust J Gen Pract. 2018 Jan-Feb;47(1-2):44-49.

5.

Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy.

Wang H, Strange C, Nietert PJ, Wang J, Turnbull TL, Cloud C, Owczarski S, Shuford B, Duke T, Gilkeson G, Luttrell L, Hermayer K, Fernandes J, Adams DB, Morgan KA.

Stem Cells Transl Med. 2018 Jan;7(1):11-19. doi: 10.1002/sctm.17-0139. Epub 2017 Nov 21.

6.

Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline.

Gupta N, Finlay GA, Kotloff RM, Strange C, Wilson KC, Young LR, Taveira-DaSilva AM, Johnson SR, Cottin V, Sahn SA, Ryu JH, Seyama K, Inoue Y, Downey GP, Han MK, Colby TV, Wikenheiser-Brokamp KA, Meyer CA, Smith K, Moss J, McCormack FX; ATS Assembly on Clinical Problems.

Am J Respir Crit Care Med. 2017 Nov 15;196(10):1337-1348. doi: 10.1164/rccm.201709-1965ST.

PMID:
29140122
7.

A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD.

Lal C, Strange C.

Expert Opin Pharmacother. 2017 Dec;18(17):1833-1843. doi: 10.1080/14656566.2017.1403583. Epub 2017 Nov 15. Review.

PMID:
29115881
8.

COPD in individuals with the PiMZ alpha-1 antitrypsin genotype.

Al Ashry HS, Strange C.

Eur Respir Rev. 2017 Oct 25;26(146). pii: 170068. doi: 10.1183/16000617.0068-2017. Print 2017 Dec 31. Review.

9.

Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease.

Kanaan R, Strange C.

Eur Respir Rev. 2017 Oct 25;26(146). pii: 170061. doi: 10.1183/16000617.0061-2017. Print 2017 Dec 31. Review.

10.

Adipose stem cells from chronic pancreatitis patients improve mouse and human islet survival and function.

Song L, Sun Z, Kim DS, Gou W, Strange C, Dong H, Cui W, Gilkeson G, Morgan KA, Adams DB, Wang H.

Stem Cell Res Ther. 2017 Aug 30;8(1):192. doi: 10.1186/s13287-017-0627-x.

11.

Adipose Stem Cell Therapy Mitigates Chronic Pancreatitis via Differentiation into Acinar-like Cells in Mice.

Sun Z, Gou W, Kim DS, Dong X, Strange C, Tan Y, Adams DB, Wang H.

Mol Ther. 2017 Nov 1;25(11):2490-2501. doi: 10.1016/j.ymthe.2017.06.016. Epub 2017 Aug 4.

PMID:
28784560
12.

Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.

Argula RG, Karwa A, Lauer A, Gregg D, Silver RM, Feghali-Bostwick C, Schanpp LM, Egbert K, Usher BW, Ramakrishnan V, Hassoun PM, Strange C.

Ann Am Thorac Soc. 2017 May;14(5):682-689. doi: 10.1513/AnnalsATS.201608-655OC.

13.

Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy.

Lal C, Strange C.

Int J Chron Obstruct Pulmon Dis. 2016 Dec 30;12:135-140. doi: 10.2147/COPD.S114273. eCollection 2017. Review.

14.

α-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction.

Wang J, Sun Z, Gou W, Adams DB, Cui W, Morgan KA, Strange C, Wang H.

Diabetes. 2017 Apr;66(4):970-980. doi: 10.2337/db16-1036. Epub 2017 Jan 9.

15.

Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

McCormack FX, Gupta N, Finlay GR, Young LR, Taveira-DaSilva AM, Glasgow CG, Steagall WK, Johnson SR, Sahn SA, Ryu JH, Strange C, Seyama K, Sullivan EJ, Kotloff RM, Downey GP, Chapman JT, Han MK, D'Armiento JM, Inoue Y, Henske EP, Bissler JJ, Colby TV, Kinder BW, Wikenheiser-Brokamp KA, Brown KK, Cordier JF, Meyer C, Cottin V, Brozek JL, Smith K, Wilson KC, Moss J; ATS/JRS Committee on Lymphangioleiomyomatosis.

Am J Respir Crit Care Med. 2016 Sep 15;194(6):748-61. doi: 10.1164/rccm.201607-1384ST.

16.

Local community playgroup participation and associations with social capital.

Strange C, Bremner A, Fisher C, Howat P, Wood L.

Health Promot J Austr. 2017 Aug;28(2):110-117. doi: 10.1071/HE15134.

PMID:
27498710
17.

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.

Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM; Sclerodema Lung Study II Investigators.

Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25.

18.

Thermal vapour ablation to reduce segmental volume in patients with severe emphysema: STEP-UP 12 month results.

Shah PL, Gompelmann D, Valipour A, McNulty WH, Eberhardt R, Grah C, Egan J, Ficker JH, Wagner M, Witt C, Liebers U, Hopkins P, Gesierich W, Phillips M, Stanzel F, Petermann C, Strange C, Snell G, Herth FJF.

Lancet Respir Med. 2016 Sep;4(9):e44-e45. doi: 10.1016/S2213-2600(16)30199-0. Epub 2016 Jul 20. No abstract available.

PMID:
27451345
19.

Reply: Asthma/COPD Overlap Syndrome and Medicare 30-Day Readmissions.

Strange C, Kumbhare S.

Ann Am Thorac Soc. 2016 Jul;13(7):1192. doi: 10.1513/AnnalsATS.201604-269LE. No abstract available.

PMID:
27388414
20.

The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult.

Sandhaus RA, Turino G, Brantly ML, Campos M, Cross CE, Goodman K, Hogarth DK, Knight SL, Stocks JM, Stoller JK, Strange C, Teckman J.

Chronic Obstr Pulm Dis. 2016 Jun 6;3(3):668-682. doi: 10.15326/jcopdf.3.3.2015.0182. Review.

21.

Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial.

Sciurba FC, Criner GJ, Strange C, Shah PL, Michaud G, Connolly TA, Deslée G, Tillis WP, Delage A, Marquette CH, Krishna G, Kalhan R, Ferguson JS, Jantz M, Maldonado F, McKenna R, Majid A, Rai N, Gay S, Dransfield MT, Angel L, Maxfield R, Herth FJ, Wahidi MM, Mehta A, Slebos DJ; RENEW Study Research Group.

JAMA. 2016 May 24-31;315(20):2178-89. doi: 10.1001/jama.2016.6261.

22.

Gender and asthma-chronic obstructive pulmonary disease overlap syndrome.

Wheaton AG, Pleasants RA, Croft JB, Ohar JA, Heidari K, Mannino DM, Liu Y, Strange C.

J Asthma. 2016 Sep;53(7):720-31. doi: 10.3109/02770903.2016.1154072. Epub 2016 Apr 6.

23.

Characteristics of COPD Patients Using United States Emergency Care or Hospitalization.

Kumbhare SD, Beiko T, Wilcox SR, Strange C.

Chronic Obstr Pulm Dis. 2016 Mar 28;3(2):539-548. doi: 10.15326/jcopdf.3.2.2015.0155.

24.

Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment.

Davis JR, Kern DM, Williams SA, Tunceli O, Wu B, Hollis S, Strange C, Trudo F.

J Manag Care Spec Pharm. 2016 Mar;22(3):293-304. doi: 10.18553/jmcp.2016.22.3.293.

25.

Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United States.

Kumbhare S, Pleasants R, Ohar JA, Strange C.

Ann Am Thorac Soc. 2016 Jun;13(6):803-10. doi: 10.1513/AnnalsATS.201508-554OC.

PMID:
26974689
26.

A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis.

Argula RG, Kokosi M, Lo P, Kim HJ, Ravenel JG, Meyer C, Goldin J, Lee HS, Strange C, McCormack FX; MILES Study Investigators.

Ann Am Thorac Soc. 2016 Mar;13(3):342-9. doi: 10.1513/AnnalsATS.201509-631OC.

27.

Respiratory and lower limb muscle function in interstitial lung disease.

Panagiotou M, Polychronopoulos V, Strange C.

Chron Respir Dis. 2016 May;13(2):162-72. doi: 10.1177/1479972315626014. Epub 2016 Jan 14. Review.

28.

Rapid oral desensitization to sirolimus in a patient with lymphangioleiomyomatosis.

Sebaaly J, Bowers L, Mazur J, Kotloff R, Olmsted BR, Kaplan A, Strange C.

J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):352-3. doi: 10.1016/j.jaip.2015.11.007. Epub 2015 Dec 24. No abstract available.

PMID:
26725158
29.

Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments.

Trudo F, Kern DM, Davis JR, Tunceli O, Zhou S, Graham EL, Strange C, Williams SA.

Int J Chron Obstruct Pulmon Dis. 2015 Sep 28;10:2055-66. doi: 10.2147/COPD.S90658. eCollection 2015.

30.

Patterns of Emphysema Heterogeneity.

Valipour A, Shah PL, Gesierich W, Eberhardt R, Snell G, Strange C, Barry R, Gupta A, Henne E, Bandyopadhyay S, Raffy P, Yin Y, Tschirren J, Herth FJ.

Respiration. 2015;90(5):402-11. doi: 10.1159/000439544. Epub 2015 Oct 3.

31.

Mothers' group participation: associations with social capital, social support and mental well-being.

Strange C, Bremner A, Fisher C, Howat P, Wood L.

J Adv Nurs. 2016 Jan;72(1):85-98. doi: 10.1111/jan.12809. Epub 2015 Sep 29.

PMID:
26420352
32.

Impact of obstructive sleep apnea syndrome on cognition in early postmenopausal women.

Lal C, DiBartolo MM, Kumbhare S, Strange C, Joseph JE.

Sleep Breath. 2016 May;20(2):621-6. doi: 10.1007/s11325-015-1261-4. Epub 2015 Sep 18.

PMID:
26385776
33.

Targeting Persons With or At High Risk for Chronic Obstructive Pulmonary Disease by State-based Surveillance.

Pleasants RA, Heidari K, Wheaton AG, Ohar JA, Strange C, Croft JB, Liao W, Mannino DM, Kraft M.

COPD. 2015;12(6):680-9. doi: 10.3109/15412555.2015.1043424. Epub 2015 Sep 14.

34.

Treatment of Alpha-1 Antitrypsin Deficiency.

Strange C, Beiko T.

Semin Respir Crit Care Med. 2015 Aug;36(4):470-7. doi: 10.1055/s-0035-1555608. Epub 2015 Aug 3. Review.

PMID:
26238635
35.

Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population.

Kern DM, Davis J, Williams SA, Tunceli O, Wu B, Hollis S, Strange C, Trudo F.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 23;10:1417-25. doi: 10.2147/COPD.S83135. eCollection 2015.

36.

Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history.

Liu Y, Pleasants RA, Croft JB, Wheaton AG, Heidari K, Malarcher AM, Ohar JA, Kraft M, Mannino DM, Strange C.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 21;10:1409-16. doi: 10.2147/COPD.S82259. eCollection 2015.

37.

Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.

Strange C, Senior RM, Sciurba F, O'Neal S, Morris A, Wisniewski SR, Bowler R, Hochheiser HS, Becich MJ, Zhang Y, Leader JK, Methé BA, Kaminski N, Sandhaus RA; GRADS Alpha-1 Study Group.

Ann Am Thorac Soc. 2015 Oct;12(10):1551-60. doi: 10.1513/AnnalsATS.201503-143OC.

38.

Body mass index, respiratory conditions, asthma, and chronic obstructive pulmonary disease.

Liu Y, Pleasants RA, Croft JB, Lugogo N, Ohar J, Heidari K, Strange C, Wheaton AG, Mannino DM, Kraft M.

Respir Med. 2015 Jul;109(7):851-9. doi: 10.1016/j.rmed.2015.05.006. Epub 2015 May 16.

39.

Cyst-based measurements for assessing lymphangioleiomyomatosis in computed tomography.

Lo P, Brown MS, Kim H, Kim H, Argula R, Strange C, Goldin JG.

Med Phys. 2015 May;42(5):2287-95. doi: 10.1118/1.4916655.

PMID:
25979023
40.

The United States Alpha-1 Foundation Research Registry: Genesis, Impact and Future.

Strange C, Monk R, Schwarz L, Walker D, Kumbhare S, Bieko T.

COPD. 2015 May;12 Suppl 1:42-5. doi: 10.3109/15412555.2015.1021914.

PMID:
25938291
41.

Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases.

Wanner A, Groft SC, Teagarden JR, Krischer J, Davis BR, Coffey CS, Hickam DH, Teckman J, Nelson DR, McCaleb ML, Loomba R, Strange C, Sandhaus RA, Brantly M, Edelman JM, Farrugia A.

Chronic Obstr Pulm Dis. 2015 Apr 28;2(2):177-190. doi: 10.15326/jcopdf.2.2.2015.0132.

42.
43.

Rebuttal from Drs Pastis and Strange.

Pastis NJ Jr, Strange CB.

Chest. 2015 Mar;147(3):598-9. doi: 10.1378/chest.14-2841. No abstract available.

PMID:
25732444
44.

Counterpoint: Should nurse practitioners perform transbronchial biopsies? No.

Pastis NJ Jr, Strange CB.

Chest. 2015 Mar;147(3):596-7. doi: 10.1378/chest.14-2840. No abstract available.

PMID:
25732442
45.

Aclidinium bromide plus formoterol for the treatment of chronic obstructive pulmonary disease.

Lal C, Strange C.

Expert Opin Pharmacother. 2015 Feb;16(3):427-34. doi: 10.1517/14656566.2015.1000861. Review. Erratum in: Expert Opin Pharmacother. 2015 Apr;16(6):939.

PMID:
25597386
46.

Impact of medications on cognitive function in obstructive sleep apnea syndrome.

Lal C, Siddiqi N, Kumbhare S, Strange C.

Sleep Breath. 2015 Sep;19(3):939-45. doi: 10.1007/s11325-014-1105-7. Epub 2015 Jan 8.

PMID:
25566945
47.

Segmental approach to lung volume reduction therapy for emphysema patients.

Bandyopadhyay S, Henne E, Gupta A, Barry R, Snell G, Strange C, Herth FJ.

Respiration. 2015;89(1):76-81. doi: 10.1159/000369036. Epub 2014 Dec 6. Review.

48.

Respiratory-swallow training in patients with head and neck cancer.

Martin-Harris B, McFarland D, Hill EG, Strange CB, Focht KL, Wan Z, Blair J, McGrattan K.

Arch Phys Med Rehabil. 2015 May;96(5):885-93. doi: 10.1016/j.apmr.2014.11.022. Epub 2014 Dec 11.

49.

The social environment and illness uncertainty in chronic obstructive pulmonary disease.

Hoth KF, Wamboldt FS, Ford DW, Sandhaus RA, Strange C, Bekelman DB, Holm KE.

Int J Behav Med. 2015 Apr;22(2):223-32. doi: 10.1007/s12529-014-9423-5.

50.

Fostering supportive community connections through mothers' groups and playgroups.

Strange C, Fisher C, Howat P, Wood L.

J Adv Nurs. 2014 Dec;70(12):2835-46. doi: 10.1111/jan.12435. Epub 2014 May 7.

PMID:
24805198

Supplemental Content

Loading ...
Support Center